121 related articles for article (PubMed ID: 29348900)
1. Validation of risk prediction models for the development of HBV-related HCC: a retrospective multi-center 10-year follow-up cohort study.
Seo YS; Jang BK; Um SH; Hwang JS; Han KH; Kim SG; Lee KS; Kim SU; Kim YS; Lee JI
Oncotarget; 2017 Dec; 8(68):113213-113224. PubMed ID: 29348900
[TBL] [Abstract][Full Text] [Related]
2. Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy.
Jung KS; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Kim BK; Han KH
Hepatology; 2015 Dec; 62(6):1757-66. PubMed ID: 26249025
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B.
Jeon MY; Lee HW; Kim SU; Kim BK; Park JY; Kim DY; Han KH; Ahn SH
Liver Int; 2018 Apr; 38(4):676-686. PubMed ID: 28865176
[TBL] [Abstract][Full Text] [Related]
4. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
[TBL] [Abstract][Full Text] [Related]
5. Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients.
Lee HW; Ahn SH
World J Gastroenterol; 2016 Oct; 22(37):8314-8321. PubMed ID: 27729738
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B.
Chon HY; Seo YS; Lee JI; Kim BS; Jang BK; Kim SG; Suk KT; Kim IH; Lee JW; Chon YE; Kim MY; Jeong SW; Lee HA; Yim SY; Um SH; Lee HW; Lee KS; Song JE; Lee CH; Chung WJ; Hwang JS; Yoo JJ; Kim YS; Kim DJ; Lee CH; Yu JH; Ha YJ; Kim MN; Lee JH; Hwang SG; Kang SH; Baik SK; Jang JY; Suh SJ; Jung YK; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Yim HJ; Kim SU;
Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):885-893. PubMed ID: 32541238
[TBL] [Abstract][Full Text] [Related]
7. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
[TBL] [Abstract][Full Text] [Related]
8. Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis.
Shin SH; Kim SU; Park JY; Kim DY; Ahn SH; Han KH; Kim BK
Liver Int; 2015 Mar; 35(3):1054-62. PubMed ID: 24930484
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.
Liu K; Wong VW; Lau K; Liu SD; Tse YK; Yip TC; Kwok R; Chan AY; Chan HL; Wong GL
Am J Gastroenterol; 2017 Dec; 112(12):1812-1823. PubMed ID: 29087391
[TBL] [Abstract][Full Text] [Related]
10. Risk assessment of liver-related events using transient elastography in patients with chronic hepatitis B receiving entecavir.
Kim MN; Kim SU; Park JY; Kim DY; Han KH; Chon CY; Ahn SH
J Clin Gastroenterol; 2014 Mar; 48(3):272-8. PubMed ID: 23811938
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).
Jung KS; Kim SU; Ahn SH; Park YN; Kim DY; Park JY; Chon CY; Choi EH; Han KH
Hepatology; 2011 Mar; 53(3):885-94. PubMed ID: 21319193
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B.
Park MS; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Shin SH; Kang W; Moon C; Han KH
Liver Int; 2015 Feb; 35(2):455-62. PubMed ID: 25183426
[TBL] [Abstract][Full Text] [Related]
13. Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events.
Oh JH; Goh MJ; Park Y; Kim J; Kang W; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Paik YH
Dig Dis Sci; 2021 Aug; 66(8):2816-2825. PubMed ID: 32897445
[TBL] [Abstract][Full Text] [Related]
14. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
[TBL] [Abstract][Full Text] [Related]
15. Reporting and Performance of Hepatocellular Carcinoma Risk Prediction Models: Based on TRIPOD Statement and Meta-Analysis.
Yang L; Wang Q; Cui T; Huang J; Jin H
Can J Gastroenterol Hepatol; 2021; 2021():9996358. PubMed ID: 34513751
[TBL] [Abstract][Full Text] [Related]
16. Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy.
Lee HW; Yoo EJ; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Han KH
Am J Gastroenterol; 2014 Aug; 109(8):1241-9. PubMed ID: 24957159
[TBL] [Abstract][Full Text] [Related]
17. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
[TBL] [Abstract][Full Text] [Related]
18. PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy.
Papatheodoridis G; Dalekos G; Sypsa V; Yurdaydin C; Buti M; Goulis J; Calleja JL; Chi H; Manolakopoulos S; Mangia G; Gatselis N; Keskin O; Savvidou S; de la Revilla J; Hansen BE; Vlachogiannakos I; Galanis K; Idilman R; Colombo M; Esteban R; Janssen HL; Lampertico P
J Hepatol; 2016 Apr; 64(4):800-6. PubMed ID: 26678008
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive assessments of liver fibrosis with transient elastography and Hui index predict survival in patients with chronic hepatitis B.
Wong GL; Chan HL; Yu Z; Wong CK; Leung C; Ho PP; Chan CY; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Chan HY; Tse CH; Wong VW
J Gastroenterol Hepatol; 2015 Mar; 30(3):582-90. PubMed ID: 25252074
[TBL] [Abstract][Full Text] [Related]
20. Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response.
Lee HW; Chon YE; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Jung KS; Park YN; Han KH
Gut Liver; 2016 May; 10(3):429-36. PubMed ID: 26347515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
